A novel purine analogue bearing nitrate ester prevents platelet activation by ROCK activity inhibition
- 1 August 2019
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 857, 172428
Abstract
No abstract availableKeywords
Funding Information
- Knowledge Foundation
This publication has 16 references indexed in Scilit:
- Discovery of 6-[4-(6-nitroxyhexanoyl)piperazin-1-yl)]-9H-purine, as pharmacological post-conditioning agentBioorganic & Medicinal Chemistry, 2012
- Signaling During Platelet Adhesion and ActivationArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Differential regulation of RhoA-mediated signaling by the TPα and TPβ isoforms of the human thromboxane A2 receptor: Independent modulation of TPα signaling by prostacyclin and nitric oxideCellular Signalling, 2008
- P2 receptors, platelet function and pharmacological implicationsThrombosis and Haemostasis, 2008
- Reciprocal cross-talk between P2Y1 and P2Y12 receptors at the level of calcium signaling in human plateletsBlood, 2004
- A2A adenosine receptors in human peripheral blood cellsBritish Journal of Pharmacology, 2000
- Biotransformation of glyceryl trinitrate by blood platelets as compared to vascular smooth muscle cellsEuropean Journal of Pharmacology, 1996
- Characterization of the l‐arginine: nitric oxide pathway in human plateletsBritish Journal of Pharmacology, 1990
- An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.Proceedings of the National Academy of Sciences, 1990
- Guanylate cyclase activation by organic nitrates in not mediated via nitriteJournal of Molecular and Cellular Cardiology, 1988